Author(s): Overton ET, Sungkanuparph S, Powderly WG, Seyfried W, Groger RK, , Overton ET, Sungkanuparph S, Powderly WG, Seyfried W, Groger RK,
Abstract Share this page
Abstract Human immunodeficiency virus (HIV)-infected patients respond poorly to hepatitis B vaccination. Records of 194 HIV-infected patients were reviewed for factors associated with successful hepatitis B vaccination. Thirty-four patients (17.5\%) developed a protective antibody response. In a logistic regression model, only a plasma HIV RNA level of <400 copies/mL at the time of vaccination was associated with a protective antibody response (P=.003).
This article was published in Clin Infect Dis
and referenced in Journal of AIDS & Clinical Research